Breakout Stocks of Week 25 @ OMX
NASDAQ was up last week (week 24) by 3.24% ending at 17,688.88 points after gaining 555.76 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Holmen Aktiebolag (publ.) OMX:HOLM-B. This stock has had a buy signal since May 30, 2024 when the price was kr436.20 , but have so far fallen -2.38% to kr425.80. Some other companies are on our watchlist to, among these are Tobii AB (publ) OMX:TOBII AB Sagax (publ) OMX:SAGA-B AB Electrolux (publ) OMX:ELUX-B and Swedish Orphan Biovitrum AB (publ) OMX:SOBI which all got a breakout pattern emerging.
| Date | Company | Price | Week 25 |
|---|---|---|---|
| Holmen Aktiebolag (publ.) | kr425.80 | kr426.80 | 0.235% |
| Tobii Ab (publ) | kr3.08 | kr3.27 | 6.37% |
| Ab Sagax (publ) | kr266.40 | kr265.80 | -0.225% |
| Ab Electrolux (publ) | kr94.94 | kr92.28 | -2.80% |
| Swedish Orphan Biovitrum Ab (publ) | kr270.00 | kr276.40 | 2.37% |
The Holmen Aktiebolag (publ.) stock price fell by -0.0939% on the last day (Friday, 14th Jun 2024) from kr426.20 to kr425.80. During the last trading day the stock fluctuated 2.13% from a day low at kr422.00 to a day high of kr431.00. The price has fallen in 7 of the last 10 days and is down by -2.38% for this period. Volume has increased on the last day by 57 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 186 thousand shares were bought and sold for approximately kr79.17 million.
Holmen Aktiebolag (publ.) holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Holmen Aktiebolag (publ.):
Addtech AB (publ.) operates as a technology trading company in Sweden, Denmark, Finland, Norway, rest of Europe, and internationally. The company operates through Automation, Electrification, Energy, Industrial Solutions, and Process Technology segments. It markets and sells intelligent solutions, subsystems, and components to industrial automation and infrastructure sector, including solutions for robotics, control systems, sensors, and industrial and communication networks. The company also offers battery systems; connectivity solutions; and intelligent power products, electronics, motors, and powertrain solutions. In addition, it produces and sells products for electricity transmission and electrical installation, as well as safety products for traffic and the home environment; and electricity distribution and communication network products to electricity network operators, contractors, wholesalers, railway companies, industrial customers, and hospitals. Further, the company produces and sells solutions and systems primarily for the forest, special vehicles, mechanical, and waste/recycling industries, as well as provides hydraulic solutions. Additionally, it provides process components, equipment, and systems for creating and processing flows; provides emission control products; and markets and sells instruments and valves for regulating and monitoring pressure, levels, flows, and energy. The company was founded in 1906 and is based in Stockholm, Sweden.
The Tobii AB (publ) stock price fell by -3.03% on the last day (Friday, 14th Jun 2024) from kr3.17 to kr3.08. During the last trading day the stock fluctuated 5.87% from a day low at kr3.00 to a day high of kr3.18. The price has fallen in 6 of the last 10 days and is down by -1.22% for this period. Volume has increased on the last day by 486 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately kr3.08 million.
Tobii AB (publ) holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Tobii AB (publ):
Tobii AB (publ) develops and sells eye-tracking technology and solutions in Sweden, rest of Europe, the United States, Canada, Asia/Oceania, and internationally. It operates in two segments, Products & Solutions, and Integrations. The Products & solutions segments provides a suite of eye tracking hardware, which includes the Tobii Pro Glasses 3; research-grade and screen-based eye trackers, such as Pro Spectrum and Pro Fusion; and the Tobii Eye Tracker 5, a gaming eye tracker. This segment also includes software Tobii Pro Lab, Sticky, and the consultancy service Tobii Pro Insight. The Integration segment offers algorithms, software, hardware components, system reference designs, and IP-licenses to provide tailored solutions to address industry-specific problems. It serves the scientific studies and research, healthcare, assistive devices, education and training, gaming, extended reality, automotive, and other sectors. The company offers its products through resellers, agents, and distributors. Tobii AB (publ) was founded in 2001 and is headquartered in Danderyd, Sweden.
The AB Sagax (publ) stock price fell by -2.06% on the last day (Friday, 14th Jun 2024) from kr272.00 to kr266.40. During the last trading day the stock fluctuated 3.88% from a day low at kr263.20 to a day high of kr273.40. The price has fallen in 6 of the last 10 days and is down by -4.45% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -83 thousand shares and in total, 232 thousand shares were bought and sold for approximately kr61.93 million.
The AB Sagax (publ) stock holds several negative signals and despite the positive trend, we believe AB Sagax (publ) will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About AB Sagax (publ):
AB Sagax (publ) operates as a property company in Sweden, Finland, France, the Netherlands, Germany, and Spain. The company invests in commercial properties primarily in the warehouse and light industry segment. As of December 31, 2021, its property portfolio consisted of 673 properties with a rental space of 3,759,000 square meters. The company was incorporated in 1995 and is based in Stockholm, Sweden.
The AB Electrolux (publ) stock price fell by -2.75% on the last day (Friday, 14th Jun 2024) from kr97.62 to kr94.94. During the last trading day the stock fluctuated 3.32% from a day low at kr94.46 to a day high of kr97.60. The price has been going up and down for this period, and there has been a -3.3% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -941 thousand shares and in total, 998 thousand shares were bought and sold for approximately kr94.73 million.
The AB Electrolux (publ) stock holds several negative signals and despite the positive trend, we believe AB Electrolux (publ) will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About AB Electrolux (publ):
Addtech AB (publ.) operates as a technology trading company in Sweden, Denmark, Finland, Norway, rest of Europe, and internationally. The company operates through Automation, Electrification, Energy, Industrial Solutions, and Process Technology segments. It markets and sells intelligent solutions, subsystems, and components to industrial automation and infrastructure sector, including solutions for robotics, control systems, sensors, and industrial and communication networks. The company also offers battery systems; connectivity solutions; and intelligent power products, electronics, motors, and powertrain solutions. In addition, it produces and sells products for electricity transmission and electrical installation, as well as safety products for traffic and the home environment; and electricity distribution and communication network products to electricity network operators, contractors, wholesalers, railway companies, industrial customers, and hospitals. Further, the company produces and sells solutions and systems primarily for the forest, special vehicles, mechanical, and waste/recycling industries, as well as provides hydraulic solutions. Additionally, it provides process components, equipment, and systems for creating and processing flows; provides emission control products; and markets and sells instruments and valves for regulating and monitoring pressure, levels, flows, and energy. The company was founded in 1906 and is based in Stockholm, Sweden.
The Swedish Orphan Biovitrum AB (publ) stock price fell by -0.81% on the last day (Friday, 14th Jun 2024) from kr272.20 to kr270.00. During the last trading day the stock fluctuated 1.95% from a day low at kr267.00 to a day high of kr272.20. The price has risen in 6 of the last 10 days but is still down by -2.81% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -26 thousand shares and in total, 185 thousand shares were bought and sold for approximately kr50.08 million.
The Swedish Orphan Biovitrum AB (publ) stock holds several negative signals and despite the positive trend, we believe Swedish Orphan Biovitrum AB (publ) will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Swedish Orphan Biovitrum AB (publ):
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
